Category: Infectious Diseases
Global Infectious Diseases
-
Infection Surveillance Solutions
... at a CAGR of 16.3% over the analysis period 2024-2030. Infection Surveillance Software, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$1.3 Billion by the end ... Read More
-
Sepsis Therapeutics
... CAGR of 6.3% over the analysis period 2024-2030. Cephalosporin, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$3.1 Billion by the end of the analysis period. ... Read More
-
Global Exosome Research Products Market Size Study, by Service (Kits, Reagents [Antibodies, Isolation Purification], Instruments), by Indication (Cancer, Infectious Diseases), by Application (Biomarkers, Vaccines), by Manufacturing Services (Stem Cell), and Regional Forecasts 2022-2032
... Exosome Research Products Market, valued at approximately USD 169 million in 2023, is poised for significant growth, with an estimated compound annual growth rate (CAGR) of 16.0% from 2024 to 2032. Exosomes, extracellular vesicles secreted ... Read More
-
2025 Certain Infectious and Parasitic Diseases Global Market Size & Growth Report with Updated Analysis & Forecasts
... growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next ... Read More
-
Global Molecular Diagnostics in Infectious Disease Testing Market Growth (Status and Outlook) 2024-2030
... million in 2023. With growing demand in downstream market, the Molecular Diagnostics in Infectious Disease Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. ... Read More
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), ROA (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Vaccine (Human, Veterinary (Companion, Livestock)), Type (Organic, Inorganic) - Global Forecast to 2029
... projected to surpass USD 0.96 billion in 2029 from USD 0.70 billion in 2024, with a significant CAGR of 6.5%. Innovations in adjuvants, such as toll-like receptor agonists, emulsions, and saponin-based compounds, increased immunization programs ... Read More
-
Deep Learning Market in Drug Discovery and Diagnostics by Therapeutic Area (Oncological Disorders, Infectious Diseases, Neurological Disorders, Immunological Disorders, Endocrine Disorders, Cardiovascular Disorders, Respiratory Disorders, Eye Disorders, Musculoskeletal Disorders, Inflammatory Disorders and Other Disorders) and Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035 DEEP LEARNING MARKET IN DRUG DISCOVERY AND DIAGNOSTICS: OVERVIEW As per Roots Analysis, the global ... Read More
-
Cell and Gene Therapy CRO Market by Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), Type of Genetic Modification (Ex vivo and In vivo), Stage of Development (Discovery, Preclinical, and Clinical), Therapeutic Area (Blood Disorders, Cardiovascular Disorders, Dermatological Disorders, Immunological Disorders, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Neurological Disorders, Oncological Disorders, Rare Diseases, and Other disorders), End-Users (Industry Players and Non-Industry Players) and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... Disorders, Cardiovascular Disorders, Dermatological Disorders, Immunological Disorders, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Neurological Disorders, Oncological Disorders, Rare Diseases, and Other disorders), End-Users (Industry Players and Non-Industry Players) and Key Geographical Regions (North America, Europe, ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
... (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry ... Read More
-
mRNA Synthesis and Manufacturing Market by Type of Product (Drug Substances (APIs) and Drug Products (FDFs)), Application Area (mRNA-based Vaccines and mRNA-based Therapeutics), Therapeutic Area (Infectious Diseases, Oncological Disorders and Other Disorders) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035 MRNA SYNTHESIS AND MANUFACTURING MARKET: OVERVIEW As per Roots Analysis, the global mRNA synthesis and manufacturing market is ... Read More
-
DNA Encoded Library Market by Application Area (Hit Generation / Identification, Hit to Lead, Hit Validation / Optimization and Other Application Areas), Therapeutic Area (Oncological Disorders, Immunological Disorders, Neurological Disorders, Respiratory Disorders, Dermatological Disorders, Cardiovascular Disorders, Infectious Diseases and Other Therapeutic Areas), End-users (Pharma / Biopharma Industry, Academic / Research Institute and Other End-users), Type of Payment Model Employed (Upfront Payment and Milestone Payment) and Key Geographical Regions (North America - US, Europe - UK, Germany, Denmark, France, Switzerland and Rest of the Europe, and Asia-Pacific - China): Industry Trends and Global Forecasts, Till 2035
... Disorders, Infectious Diseases and Other Therapeutic Areas), End-users (Pharma / Biopharma Industry, Academic / Research Institute and Other End-users), Type of Payment Model Employed (Upfront Payment and Milestone Payment) and Key Geographical Regions (North America ... Read More
-
Global Smallpox Treatment Market 2024-2028
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Nanomedicine Market Research Report: Information by Modality (Treatments and Diagnostics), by Application (Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, and Implants), and by Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Diseases, Neurological Diseases, Urological Diseases, Ophthalmological Diseases, Immunological Diseases, and Others), by Molecule Type (Nanoparticles [Albumin Particles, Inorganic Nanoparticles, Lipid Nanoparticle, Liposomes, and Others], Nanoshells, Nanotubes, and Nanodevices), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... Diseases, Ophthalmological Diseases, Immunological Diseases, and Others), by Molecule Type (Nanoparticles [Albumin Particles, Inorganic Nanoparticles, Lipid Nanoparticle, Liposomes, and Others], Nanoshells, Nanotubes, and Nanodevices), and by Region (North America, Europe, Asia-Pacific, and Rest of the ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029
... market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern. As ... Read More
-
Impact of Covid-19 on Pharmaceuticals Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... of Covid-19 on the pharmaceuticals market size was valued at USD 1,494.67 billion in 2021, and the market is now projected to grow from USD 1,585.05 billion in 2022 to USD 2,401.22 billion by 2029, ... Read More
-
2024 Global Hospital Acquired Infection Control Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Certain Infectious and Parasitic Diseases Global Market Size & Growth Report with Updated Analysis & Forecasts
... growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The ... Read More
-
Global Cytomegalovirus (CMV) Therapeutics Market 2024-2028
... (CMV) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Clinical Trials Market Analysis and Forecast to 2033: By Phase (Phase I, Phase Ii, Phase Iii, Phase Iv, Preclinical), Design (Interventional Trials, Observational Trials, Expanded Access Trials), Indication (Oncology, Cardiology, Neurology, Infectious Diseases, Gastroenterology, Immunology, Respiratory, Endocrinology, Dermatology, Ophthalmology), Study Type (Randomized Controlled Trials, Non-Randomized Controlled Trials, Adaptive Trials, Single-Arm Trials), Service Type (Clinical Trial Management, Patient Recruitment, Laboratory Services, Data Management), End User (Pharmaceutical Companies, Contract Research Organizations, Academic Institutions, Medical Device Manufacturers, Public Health Organizations), and Region
... Respiratory, Endocrinology, Dermatology, Ophthalmology), Study Type (Randomized Controlled Trials, Non-Randomized Controlled Trials, Adaptive Trials, Single-Arm Trials), Service Type (Clinical Trial Management, Patient Recruitment, Laboratory Services, Data Management), End User (Pharmaceutical Companies, Contract Research Organizations, Academic ... Read More
-
CC Chemokine Receptor Type 5 Global Market Report 2024 Including: 1) By Type: BMS-813160; AG-1105; CCL-14; DS-001 2) By Distribution Channel: Hospitals; Clinics; Online Pharmacies; Retail Pharmacies 3) By Application: Infectious Disease; Gastrointestinal; Immunology; Oncology 4) By End User: Research Institutes; Pharmaceutical Companies; Healthcare Facilities Covering: Pfizer Inc.; Sorrento Therapeutics; Merck & Co. Inc.; AbbVie Inc.; Sanofi SA
... User: Research Institutes; Pharmaceutical Companies; Healthcare FacilitiesCovering: Pfizer Inc.; Sorrento Therapeutics; Merck & Co. Inc.; AbbVie Inc.; Sanofi SA CC Chemokine Receptor Type 5 Global Market Report 2024 from The Business Research Company provides strategists, ... Read More
-
Global Pneumococcal Vaccine Market 2024-2028
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics), Diseases (Infectious, Gastrointestinal, Endocrine & Metabolic), Type (BCT/FMT, Live Biotherapeutics), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2030
... expected to reach USD 4,206.0 million in 2030 from USD 814.6 million in 2024, at a CAGR of 31.5% during the forecast period. Factors such as the collaborative efforts between the microbiome industry and academia ... Read More
-
Microbial Identification Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global microbial identification market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global microbial ... Read More
-
Zika Virus Testing
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$192.4 Million by ... Read More
-
2024 Global West Nile Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies Locations
... Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for West Nile tests performed in the following market segments: Hospitals Commercial/Private Labs Physician Offices Public Health Labs Please note: ... Read More
Research Assistance
